Jardiance
-
Boehringer Ingelheim’s Jardiance bags CDSCO approval
The drug is the first treatment for heart failure with preserved ejection fraction (HFpEF) in India Boehringer Ingelheim has received…
Read More »
The drug is the first treatment for heart failure with preserved ejection fraction (HFpEF) in India Boehringer Ingelheim has received…
Read More »